$SPCXBullishMed

SPCX Stock Alert: Here's What Analysts Are Saying Ahead of the SpaceX IPO

Oppenheimer and New Street Research initiated coverage of SpaceX’s Nasdaq-bound shares (SPCX) ahead of its June 12 listing, according to their research notes. Oppenheimer analyst Timothy Horan rated the stock “Buy” with a $190 target, citing SpaceX’s vertically integrated AI and space infrastructure. New Street’s Pierre Ferragu set a $165 target and projected $195B revenue by decade-end, with a bull case of $330.

7/10
4/10
Med
Bullish
Ahead of SpaceX’s Nasdaq listing on June 12
Bullish sell-side framing (Buy ratings and high upside targets) likely aligns with IPO momentum traders’ expectations

Analyst-initiated bullish targets ahead of the IPO can support near-term demand and sentiment, but they are not fundamental disclosures from SpaceX itself.

Oppenheimer and New Street initiated coverage on SpaceX ahead of its Nasdaq listing, setting bullish $190 and $165 price targets.

Likely positive bias into/around the Nasdaq debut, with volatility driven by positioning versus valuation expectations.

Background

The piece frames early sell-side coverage of SpaceX before it begins trading on Nasdaq, noting bypassed post-IPO quiet period because the firms were not underwriters.

Why it matters

The immediate trading relevance is sentiment/positioning into the IPO debut, driven by two new Buy initiations and explicit upside targets and revenue/value modeling.

Market relevance

Two new analyst initiations with large upside targets are timed to the June 12 Nasdaq listing, potentially influencing IPO demand and early trading sentiment.

Market effects

Could reinforce investor enthusiasm for space infrastructure/AI-in-space narratives, supporting read-across to satellite/launch/space-data themes.

Primarily US IPO/tech sentiment; may influence broader Nasdaq risk appetite around the listing window.

Limited direct global impact in the text; the main effect is on US-listed IPO positioning and valuation comps.

Alternative perspectives

High price targets ($190/$165 and bull-case $330) may be overly optimistic versus IPO pricing and early liquidity/lockup dynamics, risking post-listing mean reversion.

The article provides no new SpaceX operational datapoints (revenue, margins, contracts, or regulatory milestones); it’s valuation modeling plus analyst framing, which can fade quickly after trading begins.

Key entities

  • SpaceX

    AI-and-space infrastructure company initiating Nasdaq trading; subject of analyst coverage and price-target modeling.

  • Oppenheimer

    Initiated coverage with a Buy rating and $190 price target for SpaceX.

  • New Street Research

    Initiated coverage with a bullish $165 price objective and a bull-case $330 scenario for SpaceX.

Related articles

$SPCXMed

Beaten-down stock lets you buy SpaceX below market price

The article says Deutsche Bank initiated coverage of EchoStar (SATS) on July 7, framing it as a discounted way to own SpaceX. It cites a $143 price target and a claim that SATS offers about a 20% discount versus SpaceX. It notes EchoStar holds about $11 billion of SpaceX Class A shares, while EchoStar fell 23% since SpaceX’s IPO and is expected to report Q2 results July 30.

$SPCXMed

SpaceX Doubles Prices for Starlink Aviation Plans, Raises Hardware Cost to $200,000

Space Exploration Technologies (NASDAQ:SPCX) raised Starlink Business Aviation plan prices, according to a post on X. The Aviation Regional 25GB is $4,000/month (from $2,000), Regional Unlimited is $12,500/month, and Global Unlimited is $20,000/month (from $10,000). Starlink aviation hardware is $200,000 (from $145,000), with customer migration in August. Morgan Stanley cited a $600/share bull case.

$SPCXMed

SpaceX releases Grok 4.5, first model built alongside Cursor

SpaceX (NASDAQ:SPCX) released Grok 4.5, its first major AI model update built with Cursor for coding and agentic workflows. The 1.5T-parameter model was trained on tens of thousands of GB300 GPUs and follows Grok 4.3. SpaceX cites improved benchmark performance and lower pricing, $2 per 1M input tokens and $6 per 1M output. UBS reiterated a Buy and $210 target.

$SPCXMed

Elon Musk's Grok 4.5 Could Rewrite Enterprise AI Economics - SpaceX (NASDAQ:SPCX)

SpaceXAI, a wholly owned unit of Space Exploration Technologies Corp. (NASDAQ:SPCX), launched Grok 4.5 for coding and research-heavy tasks. The company says it is its strongest model and was trained alongside Cursor. Pricing is $2 per million input tokens and $6 per million output tokens, lower than Claude Opus 4.8, according to Counterpoint analyst Neil Shah. Shares were up 0.88% premarket at $149.60.

$SPCXMed

Jim Chanos Highlights Morgan Stanley's $672 Billion Funding Warning on Elon Musk's SpaceX - SpaceX (NASDA

Jim Chanos highlighted Morgan Stanley’s note on SpaceX’s funding needs, citing a multi-year external capital requirement of about $672 billion and no free-cash-flow positive period until 2035. Morgan Stanley kept an “Overweight” stance with a $300 price target, while warning SpaceX may need equity issuance or slower deployment if debt markets fail. SPCX listed June 12, 2026.